Cargando…
Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)
BACKGROUND: Despite recent advances in immunosuppressive therapy for patients with primary nephrotic syndrome, its effectiveness and safety have not been fully studied in recent nationwide real-world clinical data in Japan. METHODS: A 5-year cohort study, the Japan Nephrotic Syndrome Cohort Study, e...
Ejemplares similares
-
Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS)
por: Kimura, Tomonori, et al.
Publicado: (2022) -
Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study
por: Yamamoto, Ryohei, et al.
Publicado: (2022) -
Acute Kidney Injury and Remission of Proteinuria in Minimal Change Disease
por: Yamamoto, Ryohei, et al.
Publicado: (2022) -
A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome
por: Muso, Eri, et al.
Publicado: (2015) -
Evidence-based clinical practice guidelines for nephrotic syndrome 2014
por: Nishi, Shinichi, et al.
Publicado: (2016)